Reason for request

Re-assessment of the Actual Benefit

-


Clinical Benefit

Insufficient

The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".


Therapeutic use

-